BeStock  

Chemed CHE

US equityMarket cap rank #1713Medical Care Facilities
$548.59 −$2.74 (-0.50%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $548.70 +0.02%
Open$556.34
Prev close$551.33
Day range$545.36 – $559.90
Volume160.2K
Market cap$7.11B
P/E (TTM)26.3
Dividend yield0.46%

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership109.1%+2.33 pts vs. prior quarter
Institutions holding644+21 vs. prior quarter
Insider trades (recent)25 buys / 25 sellsBalanced
Short interest6.14% of floatDays to cover 5.1 · as of 30 Oct 2026
Short-sale volume share17.2%5-day average of daily volume

Short-sale volume as % of daily volume

6%13%20%27%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$8.08M (8 inflow days, 12 outflow days).

Net flow by order size, last 20 sessions

+$290.0KSuper−$8.4MBig−$11.6MMid−$11.9MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 33.3% of shares outstanding.

Largest holders

  • BlackRock11.21%
  • AQR Capital Management7.45%
  • Vanguard Portfolio Management, LLC6.60%
  • Vanguard Capital Management, LLC4.53%
  • Acadian Asset Management LLC3.56%
  • State Street Global Advisors3.39%
  • Geode Capital Management, LLC3.10%
  • Boston Partners Global Investors, Inc.2.91%

By investor type

  • Mutual Fund81.58%
  • Hedge Fund13.13%
  • Public Company6.62%
  • Private Company3.08%
  • Government Pension Fund2.45%
  • Individual/Insider1.59%
  • Sovereign Wealth Fund1.26%
  • Family Office/Trust0.55%

Reported short interest has risen from 4.91% to 6.14% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Boston Partners Global Investors, Inc. Mutual Fund 2026/Q3 +96,311 2.9%
Vanguard Portfolio Management, LLC Mutual Fund 2026/Q3 +68,470 6.6%
Los Angeles Capital Management LLC Mutual Fund 2026/Q3 +46,403 0.4%
Assenagon Asset Management S.A. Mutual Fund 2026/Q3 +43,304 0.3%
Fideuram Asset Management (Ireland) DAC Mutual Fund 2026/Q3 +31,183 0.2%
Thrivent Investment Management, Inc. Mutual Fund 2026/Q3 +26,053 0.2%
Jane Street Group, LLC Private Company 2026/Q3 +25,107 0.2%
Morgan Stanley Investment Management Inc. Mutual Fund 2026/Q3 +23,521 2.0%
AQR Capital Management Hedge Fund 2026/Q3 +552,596 7.5%
Boston Partners Global Investors, Inc. Mutual Fund 2026/Q3 +259,114 2.2%
River Road Asset Management, LLC Mutual Fund 2026/Q3 +166,159 1.8%
BlackRock Mutual Fund 2026/Q3 +147,592 11.4%
Acadian Asset Management LLC Mutual Fund 2026/Q3 +146,352 3.5%
SG Americas Securities, LLC Private Company 2026/Q3 +105,288 1.0%
Fuller & Thaler Asset Management, Inc. Mutual Fund 2026/Q3 +92,595 1.7%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
10 Nov 2026 Spencer Lee Executive Vice President Open Market Disposition -1,000 $547.61 12,931
2 Nov 2026 Kevin McNamara Chief Executive Officer Open Market Disposition -2,000 $537.90 82,220
1 Nov 2026 Spencer Lee Executive Vice President Open Market Disposition -920 $537.17 13,931
19 Oct 2026 Kevin McNamara Chief Executive Officer Other Derivative Acquisition +36,693 $512.64 300,851
19 Oct 2026 Spencer Lee Executive Vice President Other Derivative Acquisition +7,125 $512.64 23,222
19 Oct 2026 Thomas Hutton Officer Other Derivative Acquisition +3,964 $512.64 26,053
19 Oct 2026 Michael Witzeman Executive VP, Controller, Principal Accounting Officer & CFO Other Derivative Acquisition +12,686 $512.64 66,656
19 Oct 2026 Brian Judkins VP, Secretary & Chief Legal Officer Other Derivative Acquisition +9,392 $512.64 40,673
19 Oct 2026 Joel Wherley Executive VP and President & CEO of VITAS Healthcare Other Derivative Acquisition +12,686 $512.64 42,906
29 Sep 2026 Spencer Lee Executive Vice President Derivative Exercise and Sale -11,160 $508.93 14,851
29 Sep 2026 Spencer Lee Executive Vice President Derivative Exercise and Retained +939 $445.35 14,851
27 Sep 2026 Kevin McNamara Chief Executive Officer Open Market Disposition -2,000 $513.45 66,418
27 Sep 2026 Thomas Hutton Officer Derivative Exercise and Sale -4,270 $506.65 80,321
27 Sep 2026 Thomas Hutton Officer Derivative Exercise and Retained +359 $445.35 80,321
17 Sep 2026 Kevin McNamara Chief Executive Officer Open Market Disposition -2,000 $501.40 68,418
20 Aug 2026 Kevin McNamara Chief Executive Officer Open Market Disposition -2,000 $541.16 70,418
20 Aug 2026 Spencer Lee Executive Vice President Open Market Disposition -1,000 $541.04 13,912
9 Aug 2026 Brian Judkins VP, Secretary & Chief Legal Officer Derivative Exercise and Sale -5,878 $548.96 3,344
9 Aug 2026 Brian Judkins VP, Secretary & Chief Legal Officer Derivative Exercise and Retained +908 $445.35 3,344
4 Aug 2026 Joel Wherley Executive VP and President & CEO of VITAS Healthcare Derivative Exercise and Sale -2,270 $542.62 1,181

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 795,988 6.1% 5.1
15 Oct 2026 685,972 5.3% 4.9
30 Sep 2026 596,751 4.6% 3.3
15 Sep 2026 653,250 5.0% 5.4
31 Aug 2026 564,624 4.3% 3.8
14 Aug 2026 638,408 4.9% 3.7

Discussion

No comments yet — be the first to weigh in on CHE.

Sign in to join the discussion.

Scroll to Top